Modulation of the PD-1 pathway by inhibitory antibody superagonists

Modulation of the PD-1 pathway by inhibitory antibody superagonists

<p>In metozoans, most of the key events that lead to cell activation and inhibition are controlled by tyrosine phosphorylation. Extracellular signals are transmitted by membrane bound receptors, which have intrinsic kinase activity or themselves recruit intracellular kinases to specialised inh...

Descripció completa

Dades bibliogràfiques
Autor principal:	Akkaya, B
Altres autors:	Davis, S
Format:	Thesis
Idioma:	English
Publicat:	2012
Matèries:	Immunology

Ítems similars

Second generation superagonistic anti-PD-1 antibodies
per: Yu, SY
Publicat: (2019)

Inhibitory superagonistic antibodies as novel therapeutics
per: Donat, RF
Publicat: (2023)

In vivo characterization of inhibitory anti-PD-1 antibody superagonists
per: Akkaya, B, et al.
Publicat: (2011)

Regulation of human and mouse bystander T cell activation responses by PD-1
per: Catherine T. Le, et al.
Publicat: (2023-09-01)

Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
per: Jeffrey Schlom, et al.
Publicat: (2020-05-01)

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
per: Ling Ding, et al.
Publicat: (2023-01-01)

PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis
per: Dakota B. Poschel, et al.
Publicat: (2024-10-01)

Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells
per: Ting Zhao, et al.
Publicat: (2022-09-01)

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.
per: Lühder, F, et al.
Publicat: (2003)

Glioblastoma extracellular vesicles modulate immune PD-L1 expression in accessory macrophages upon radiotherapy
per: Markus W. Schweiger, et al.
Publicat: (2024-02-01)

PD-1 deficiency impairs eosinophil recruitment to tissue during Trichinella spiralis infection
per: Yiqi Liu, et al.
Publicat: (2024-11-01)

Modulation of regulatory T cell function through specific molecular pathways in transplantation
per: Kawai, K
Publicat: (2020)

Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs
per: Janine Becker-Gotot, et al.
Publicat: (2022-11-01)

Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells
per: Catarina Sacristán, et al.
Publicat: (2024-08-01)

Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
per: Jani Huuhtanen, et al.
Publicat: (2023-03-01)

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity
per: Ethan P. Oxley, et al.
Publicat: (2024-10-01)

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
per: Andrea Ziblat, et al.
Publicat: (2024-05-01)

IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression
per: Thibault Hirsch, et al.
Publicat: (2024-07-01)

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity
per: Qingyu Lin, et al.
Publicat: (2023-06-01)

Generation of bispecific antibodies by structure-guided redesign of IgG constant regions
per: Iwasaki, Yordkhwan W., et al.
Publicat: (2023)

Identification of a PD-L1+Tim-1+ iNKT subset that protects against fine particulate matter–induced airway inflammation
per: Christina Li-Ping Thio, et al.
Publicat: (2022-12-01)

Imaging-based analysis of antibody superagonism
per: Aßmann, MC
Publicat: (2016)

Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti–PD-1 resistance in non–small cell lung cancer
per: Jessica M. Konen, et al.
Publicat: (2023-09-01)

Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases
per: Ting Jiang, et al.
Publicat: (2022-10-01)

Modulators of MHC class I-related protein 1-mediated antigen presentation
per: Kulicke, CA
Publicat: (2018)

Modulation of receptor for advanced glycation end products signal transduction pathway as therapeutic option for malaria therapy
per: Chuah, Yaw Kuang
Publicat: (2015)

Mechanisms of co-stimulatory and inhibitory receptors in human cancer-specific cytotoxic T cells
per: Bin Abd Hamid, M
Publicat: (2019)

Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
per: Jacob A. Myers, et al.
Publicat: (2022-08-01)

Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction
per: Maximillian A. Robinson, et al.
Publicat: (2024-09-01)

Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models
per: Xiang Li, et al.
Publicat: (2023-04-01)

Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides
per: James H. Schofield, et al.
Publicat: (2024-04-01)

The diversity of inhibitory receptor co-expression patterns of exhausted CD8+ T cells in oropharyngeal carcinoma
per: Yufang Rao, et al.
Publicat: (2024-05-01)

Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage
per: Rosemarie D. Mason, et al.
Publicat: (2025-01-01)

Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant
per: Junhao Fan, et al.
Publicat: (2024-08-01)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
per: Satomi Ando, et al.
Publicat: (2023-01-01)

Antibody applications : essential techniques /
per: 211968 Delves, Peter J.
Publicat: (1995)

Large-scale antibody immune response mapping of splenic B cells and bone marrow plasma cells in a transgenic mouse model
per: Pan, Xiaoli, et al.
Publicat: (2023)

Development and characterisation of human monoclonal antibodies against the Ebola virus glycoprotein
per: Mendelsohn, S
Publicat: (2014)

Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem
per: Qi Wen Teo, et al.
Publicat: (2023-11-01)

2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist.
per: Fliegert, R, et al.
Publicat: (2017)